These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 17383899)

  • 1. Detection and measurement of neurofibromatosis-1 mouse optic glioma in vivo.
    Banerjee D; Hegedus B; Gutmann DH; Garbow JR
    Neuroimage; 2007 May; 35(4):1434-7. PubMed ID: 17383899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of coexisting genetic mutations on murine optic glioma biology.
    Kaul A; Toonen JA; Gianino SM; Gutmann DH
    Neuro Oncol; 2015 May; 17(5):670-7. PubMed ID: 25246427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history of neurofibromatosis 1-associated optic nerve glioma in mice.
    Bajenaru ML; Garbow JR; Perry A; Hernandez MR; Gutmann DH
    Ann Neurol; 2005 Jan; 57(1):119-27. PubMed ID: 15622533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optic nerve glioma in mice requires astrocyte Nf1 gene inactivation and Nf1 brain heterozygosity.
    Bajenaru ML; Hernandez MR; Perry A; Zhu Y; Parada LF; Garbow JR; Gutmann DH
    Cancer Res; 2003 Dec; 63(24):8573-7. PubMed ID: 14695164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NG2-cells are not the cell of origin for murine neurofibromatosis-1 (Nf1) optic glioma.
    Solga AC; Gianino SM; Gutmann DH
    Oncogene; 2014 Jan; 33(3):289-99. PubMed ID: 23318450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optic nerve dysfunction in a mouse model of neurofibromatosis-1 optic glioma.
    Hegedus B; Hughes FW; Garbow JR; Gianino S; Banerjee D; Kim K; Ellisman MH; Brantley MA; Gutmann DH
    J Neuropathol Exp Neurol; 2009 May; 68(5):542-51. PubMed ID: 19525901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into optic pathway glioma vision loss from mouse models of neurofibromatosis type 1.
    Freret ME; Gutmann DH
    J Neurosci Res; 2019 Jan; 97(1):45-56. PubMed ID: 29704429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rare case of optic pathway glioma with extensive intra-ocular involvement in a child with neurofibromatosis type 1.
    Gupta V; Sabri K; Whelan KF; Viscardi V
    Middle East Afr J Ophthalmol; 2015; 22(1):117-8. PubMed ID: 25624686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining the temporal course of murine neurofibromatosis-1 optic gliomagenesis reveals a therapeutic window to attenuate retinal dysfunction.
    Toonen JA; Ma Y; Gutmann DH
    Neuro Oncol; 2017 Jun; 19(6):808-819. PubMed ID: 28039362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical cancer therapy in a mouse model of neurofibromatosis-1 optic glioma.
    Hegedus B; Banerjee D; Yeh TH; Rothermich S; Perry A; Rubin JB; Garbow JR; Gutmann DH
    Cancer Res; 2008 Mar; 68(5):1520-8. PubMed ID: 18316617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurofibromatosis type 1 and optic pathway gliomas: follow-up of 54 patients.
    Thiagalingam S; Flaherty M; Billson F; North K
    Ophthalmology; 2004 Mar; 111(3):568-77. PubMed ID: 15019338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concomitant meningioma and glioma within the same optic nerve in neurofibromatosis type 1.
    Büyükkapu-Bay S; Akça A; Karadoğan M; Çorapçioğlu F; Anik Y
    J Child Neurol; 2014 Mar; 29(3):385-8. PubMed ID: 23420652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optic-nerve gliomas, chiasmal gliomas and neurofibromatosis type 1.
    Sylvester CL; Drohan LA; Sergott RC
    Curr Opin Ophthalmol; 2006 Feb; 17(1):7-11. PubMed ID: 16436918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spatiotemporal differences in CXCL12 expression and cyclic AMP underlie the unique pattern of optic glioma growth in neurofibromatosis type 1.
    Warrington NM; Woerner BM; Daginakatte GC; Dasgupta B; Perry A; Gutmann DH; Rubin JB
    Cancer Res; 2007 Sep; 67(18):8588-95. PubMed ID: 17875698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen activation of microglia underlies the sexually dimorphic differences in Nf1 optic glioma-induced retinal pathology.
    Toonen JA; Solga AC; Ma Y; Gutmann DH
    J Exp Med; 2017 Jan; 214(1):17-25. PubMed ID: 27923908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrastructural characterization of the optic pathway in a mouse model of neurofibromatosis-1 optic glioma.
    Kim KY; Ju WK; Hegedus B; Gutmann DH; Ellisman MH
    Neuroscience; 2010 Sep; 170(1):178-88. PubMed ID: 20600672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NF1 germline mutation differentially dictates optic glioma formation and growth in neurofibromatosis-1.
    Toonen JA; Anastasaki C; Smithson LJ; Gianino SM; Li K; Kesterson RA; Gutmann DH
    Hum Mol Genet; 2016 May; 25(9):1703-13. PubMed ID: 26908603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optic Gliomas: Past, Present, and Future.
    Miller NR
    J Neuroophthalmol; 2016 Dec; 36(4):460-473. PubMed ID: 27798428
    [No Abstract]   [Full Text] [Related]  

  • 19. NF1 mutation-driven neuronal hyperexcitability sets a threshold for tumorigenesis and therapeutic targeting of murine optic glioma.
    Anastasaki C; Chatterjee J; Koleske JP; Gao Y; Bozeman SL; Kernan CM; Marco Y Marquez LI; Chen JK; Kelly CE; Blair CJ; Dietzen DJ; Kesterson RA; Gutmann DH
    Neuro Oncol; 2024 Aug; 26(8):1496-1508. PubMed ID: 38607967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3-D imaging mass spectrometry of protein distributions in mouse Neurofibromatosis 1 (NF1)-associated optic glioma.
    Anderson DM; Van de Plas R; Rose KL; Hill S; Schey KL; Solga AC; Gutmann DH; Caprioli RM
    J Proteomics; 2016 Oct; 149():77-84. PubMed ID: 26883872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.